Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NeuroNexus is a leading neurotechnology company that specializes in the design and manufacture of high-density microelectrode arrays and advanced instrumentation for neuroscience research and clinical applications. Spun out of the University of Michigan, the company provides a comprehensive suite of neural interface solutions, including silicon probes, electrophysiology systems, and sophisticated data analysis software. Their technology is a standard in academic and industrial laboratories worldwide for mapping brain activity and developing next-generation treatments for neurological and psychiatric disorders. NeuroNexus also focuses on translating its research-grade technology into clinical-grade interfaces for human use in brain-computer interface (BCI) applications. The company's products enable high-resolution recording and stimulation of neural populations, facilitating breakthroughs in understanding brain function.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NeuroNexus.